These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9634482)

  • 1. The HLA-B* 1516 motif demonstrates HLA-B-specific P2 pocket characteristics.
    Seeger FH; Arnold D; Dumrese T; de la Salle H; Fricker D; Schild H; Rammensee HG; Stevanović S
    Immunogenetics; 1998 Jul; 48(2):156-60. PubMed ID: 9634482
    [No Abstract]   [Full Text] [Related]  

  • 2. Peptide motifs of HLA-B38 and B39 molecules.
    Falk K; Rötzschke O; Takiguchi M; Gnau V; Stevanović S; Jung G; Rammensee HG
    Immunogenetics; 1995; 41(2-3):162-4. PubMed ID: 7806291
    [No Abstract]   [Full Text] [Related]  

  • 3. Crystal structures of two peptide-HLA-B*1501 complexes; structural characterization of the HLA-B62 supertype.
    Røder G; Blicher T; Justesen S; Johannesen B; Kristensen O; Kastrup J; Buus S; Gajhede M
    Acta Crystallogr D Biol Crystallogr; 2006 Nov; 62(Pt 11):1300-10. PubMed ID: 17057332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide motifs of HLA-B58, B60, B61, and B62 molecules.
    Falk K; Rötzschke O; Takiguchi M; Gnau V; Stevanović S; Jung G; Rammensee HG
    Immunogenetics; 1995; 41(2-3):165-8. PubMed ID: 7806292
    [No Abstract]   [Full Text] [Related]  

  • 5. Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501.
    Røder G; Kristensen O; Kastrup JS; Buus S; Gajhede M
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Jun; 64(Pt 6):459-62. PubMed ID: 18540051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HLA-Bw75 subtype of B15: molecular characterization and comparison with crossreacting antigens.
    Little AM; Parham P
    Tissue Antigens; 1991 Oct; 38(4):186-90. PubMed ID: 1801311
    [No Abstract]   [Full Text] [Related]  

  • 7. Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides.
    Griffin TA; Yuan J; Friede T; Stevanovic S; Ariyoshi K; Rowland-Jones SL; Rammensee HG; Colbert RA
    J Immunol; 1997 Nov; 159(10):4887-97. PubMed ID: 9366414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5, -B35 complex.
    Sakaguchi T; Takamiya Y; Edidin M; Nokihara K; Miwa K; Schönbach C; Takiguchi M
    Immunogenetics; 1998; 47(2):149-58. PubMed ID: 9396861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B15 peptide ligands are preferentially anchored at their C termini.
    Prilliman KR; Jackson KW; Lindsey M; Wang J; Crawford D; Hildebrand WH
    J Immunol; 1999 Jun; 162(12):7277-84. PubMed ID: 10358176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexity among constituents of the HLA-B*1501 peptide motif.
    Prilliman KR; Lindsey M; Jackson KW; Cole J; Bonner R; Hildebrand WH
    Immunogenetics; 1998 Jul; 48(2):89-97. PubMed ID: 9634472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide motif of the class I molecule HLA-B*1503.
    Prilliman KR; Lindsey M; Wang J; Jackson KW; Hildebrand WH
    Immunogenetics; 1999 Feb; 49(2):144-6. PubMed ID: 9887352
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA-B15: a widespread and diverse family of HLA-B alleles.
    Hildebrand WH; Domena JD; Shen SY; Lau M; Terasaki PI; Bunce M; Marsh SG; Guttridge MG; Bias WB; Parham P
    Tissue Antigens; 1994 Apr; 43(4):209-18. PubMed ID: 7521976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide motif of HLA-B*1510.
    Seeger FH; Schirle M; Keilholz W; Rammensee HG; Stevanović S
    Immunogenetics; 1999 Oct; 49(11-12):996-9. PubMed ID: 10501844
    [No Abstract]   [Full Text] [Related]  

  • 14. Allelic variations clustered in the antigen binding sites of HLA-Bw62 molecules.
    Choo SY; Fan LA; Hansen JA
    Immunogenetics; 1993; 37(2):108-13. PubMed ID: 8423049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.
    Sidney J; Southwood S; del Guercio MF; Grey HM; Chesnut RW; Kubo RT; Sette A
    J Immunol; 1996 Oct; 157(8):3480-90. PubMed ID: 8871647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new HLA-B15 allele (B*1541) found in a Mexican of Nahua (Aztec) descent.
    Olivo-Díaz A; Gomez-Casado E; Gorodezky C; Martinez-Laso J; Longás J; González-Hevilla M; Alvarez M; Arnaiz-Villena A
    Immunogenetics; 1998 Jul; 48(2):148-51. PubMed ID: 9634480
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction.
    Hildebrand WH; Turnquist HR; Prilliman KR; Hickman HD; Schenk EL; McIlhaney MM; Solheim JC
    Hum Immunol; 2002 Apr; 63(4):248-55. PubMed ID: 12039406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative and quantitative differences in peptides bound to HLA-B27 in the presence of mouse versus human tapasin define a role for tapasin as a size-dependent peptide editor.
    Sesma L; Galocha B; Vázquez M; Purcell AW; Marcilla M; McCluskey J; López de Castro JA
    J Immunol; 2005 Jun; 174(12):7833-44. PubMed ID: 15944288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
    Gumperz JE; Barber LD; Valiante NM; Percival L; Phillips JH; Lanier LL; Parham P
    J Immunol; 1997 Jun; 158(11):5237-41. PubMed ID: 9164941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-2 domain polymorphism and HLA class I peptide loading.
    Prilliman KR; Crawford D; Hickman HD; Jackson KW; Wang J; Hildebrand WH
    Tissue Antigens; 1999 Nov; 54(5):450-60. PubMed ID: 10599884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.